MC1968A1 - Procede de preparation de composes antiviraux et procede de preparation de formulations pharmaceutiques les contenant - Google Patents

Procede de preparation de composes antiviraux et procede de preparation de formulations pharmaceutiques les contenant

Info

Publication number
MC1968A1
MC1968A1 MC881999A MC1999A MC1968A1 MC 1968 A1 MC1968 A1 MC 1968A1 MC 881999 A MC881999 A MC 881999A MC 1999 A MC1999 A MC 1999A MC 1968 A1 MC1968 A1 MC 1968A1
Authority
MC
Monaco
Prior art keywords
compound
formula
group
pharmaceutically acceptable
atom
Prior art date
Application number
MC881999A
Other languages
English (en)
French (fr)
Inventor
Thomas Anthony Krenitsky
Lilia Marie Beauchamp
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26292613&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MC1968(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB878719367A external-priority patent/GB8719367D0/en
Priority claimed from GB878725939A external-priority patent/GB8725939D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MC1968A1 publication Critical patent/MC1968A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
MC881999A 1987-08-15 1988-08-11 Procede de preparation de composes antiviraux et procede de preparation de formulations pharmaceutiques les contenant MC1968A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878719367A GB8719367D0 (en) 1987-08-15 1987-08-15 Therapeutic compounds
GB878725939A GB8725939D0 (en) 1987-11-05 1987-11-05 Therapeutic compounds

Publications (1)

Publication Number Publication Date
MC1968A1 true MC1968A1 (fr) 1989-09-29

Family

ID=26292613

Family Applications (1)

Application Number Title Priority Date Filing Date
MC881999A MC1968A1 (fr) 1987-08-15 1988-08-11 Procede de preparation de composes antiviraux et procede de preparation de formulations pharmaceutiques les contenant

Country Status (30)

Country Link
EP (2) EP0308065B1 (da)
JP (2) JPH0662623B2 (da)
KR (2) KR960002849B1 (da)
CN (1) CN1033701C (da)
AP (2) AP160A (da)
AT (1) ATE138660T1 (da)
AU (1) AU612393C (da)
CS (1) CS276903B6 (da)
CY (1) CY1833A (da)
DE (1) DE3855333T2 (da)
DK (2) DK170045B1 (da)
ES (1) ES2087639T3 (da)
FI (1) FI89713C (da)
GR (1) GR3020372T3 (da)
HU (1) HU201071B (da)
IE (1) IE65551B1 (da)
IL (1) IL87434A (da)
LU (1) LU88746I2 (da)
LV (1) LV5264A3 (da)
MC (1) MC1968A1 (da)
MX (1) MX9203418A (da)
MY (1) MY103760A (da)
NL (1) NL960001I2 (da)
NO (2) NO167805C (da)
NZ (1) NZ225809A (da)
PL (1) PL158285B1 (da)
PT (1) PT88261B (da)
SA (1) SA95160244B1 (da)
SG (1) SG26346G (da)
SU (1) SU1634138A3 (da)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP160A (en) * 1987-08-15 1991-11-18 The Wellcome Foundation Ltd Therapeutic acyclic nucleosides.
GB8816760D0 (en) * 1988-07-14 1988-08-17 Wellcome Found Therapeutic compounds
GB8829571D0 (en) * 1988-12-19 1989-02-08 Wellcome Found Antiviral compounds
DE68922903T2 (de) * 1988-12-19 1995-11-23 Wellcome Found Antivirale Pyrimidin- und Purinverbindungen, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate.
DE4008858A1 (de) * 1990-03-20 1991-09-26 Hoechst Ag Substituierte purine, verfahren zu ihrer hertellung sowie ihre verwendung als antivirale mittel
DK0702683T3 (da) * 1993-06-08 2004-02-02 Cancer Rec Tech Ltd 06-substituerede guaninderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf i behandling af tumorceller
DE69426880T2 (de) * 1993-06-10 2001-10-31 Rolabo S.L., Zaragoza Verfahren zur herstellung von aminosäureester von nukleosid analogen
GB9317146D0 (en) * 1993-08-18 1993-10-06 Wellcome Found Therapeutic combinations
GB9320316D0 (en) * 1993-10-01 1993-11-17 Smithkline Beecham Plc Pharmaceuticals
TW282470B (da) * 1993-11-18 1996-08-01 Ajinomoto Kk
EP0665229B1 (en) * 1994-02-01 1999-11-17 Ajinomoto Co., Inc. Process for the production of nucleic acid base derivatives
US5840891A (en) * 1994-07-28 1998-11-24 Syntex (U.S.A.) Inc. 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
PE32296A1 (es) * 1994-07-28 1996-08-07 Hoffmann La Roche Ester de l-monovalina derivado de 2-(2-amino-1,6-dihidro-6-oxo-purin-9-il) metoxi-1,3-propandiol y sus sales farmaceuticamente aceptables
US5543414A (en) * 1994-07-28 1996-08-06 Syntex (Usa) Inc. Achiral amino acid acyl esters of ganciclovir and its derivatives
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
GB9501178D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Guanine derivative
GB9501142D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Compounds for use in medicine
DE19536164A1 (de) * 1995-09-28 1997-04-03 Boehringer Ingelheim Kg Verbessertes Verfahren zur Herstellung von 9-[(2-Hyroxyethoxy)methyl]guanin (Acyclovir)
EP0874631B1 (en) * 1996-01-19 2003-11-19 Glaxo Group Limited Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application
US5756736A (en) * 1996-01-26 1998-05-26 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US5840890A (en) * 1996-01-26 1998-11-24 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
CA2243650C (en) * 1996-01-26 2006-08-15 F. Hoffmann-La Roche Ag Process for preparing purine derivatives
US5700936A (en) * 1996-01-26 1997-12-23 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate
US6040446A (en) 1996-01-26 2000-03-21 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
US5869493A (en) 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
US6703394B2 (en) 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
IT1283447B1 (it) * 1996-07-18 1998-04-21 Ind Chimica Srl Processo di preparazione del valaciclovir e relativi intermedi
WO1998031683A1 (en) * 1997-01-17 1998-07-23 Ajinomoto Co., Inc. Novel z-valacyclovir crystals
CA2332961A1 (en) * 1998-05-21 1999-11-25 Michael Zasloff A method for stimulation of defensin production by exposure to isoleucine
CZ2004446A3 (cs) * 2001-09-07 2005-01-12 Teva Pharmaceutical Industries Ltd. Krystalické formy valaciklovir hydrochloridu
WO2004000265A2 (en) 2002-06-24 2003-12-31 Ranbaxy Laboratories Limited Process for the preparation of robust formulations of valacyclovir hydrochloride tablets
US20050043329A1 (en) * 2002-09-06 2005-02-24 Shlomit Wizel Crystalline forms of valacyclovir hydrochloride
CN1309732C (zh) * 2002-10-28 2007-04-11 南京长澳医药科技有限公司 6－烷氧基－2’，3’－双脱氧鸟嘌呤核苷的制备方法
TW200510414A (en) * 2003-06-02 2005-03-16 Teva Pharma Novel crystalline forms of valacyclovir hydrochloride
CN1331471C (zh) * 2003-09-22 2007-08-15 陈云芳 盐酸万乃洛韦软胶囊组合物
JP2007522130A (ja) * 2004-01-21 2007-08-09 テバ ファーマシューティカル インダストリーズ リミティド 塩酸バラシクロビルの調製方法
GB2413017A (en) * 2004-04-06 2005-10-12 Ford Global Tech Llc An electrical connector for a vehicle
WO2006035452A1 (en) * 2004-09-27 2006-04-06 Matrix Laboratories Ltd Novel pseudomorph of valaciclovir hydrochloride
WO2006127217A2 (en) 2005-05-25 2006-11-30 Eli Lilly And Company Cyclopropanecarboxylate esters of acyclovir
EP1746098A1 (en) 2005-07-21 2007-01-24 SOLMAG S.p.A. Valacyclovir polymorphs and a process for the preparation thereof
CN101456859B (zh) * 2009-01-06 2011-07-20 华南理工大学 抗病毒药物缬昔洛韦的制备方法
WO2011158252A1 (en) 2010-06-15 2011-12-22 Matrix Laboratories Ltd Process for the preparation of valacyclovir hydrochloride polymorphic form ii
CN102850354B (zh) * 2012-10-10 2014-07-23 山东金城医药化工股份有限公司 高纯度cbz-万乃洛韦的制备方法
CN106632335A (zh) * 2016-12-27 2017-05-10 河南康达制药有限公司 一种盐酸伐昔洛韦的制备方法
RU2750867C1 (ru) * 2020-05-18 2021-07-05 Александр Сергеевич Самойлов Производные гуанина

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8202626A (nl) * 1982-06-29 1984-01-16 Stichting Rega V Z W Derivaten van 9-(2-hydroxyethoxymethyl)guanine.
DE3627024A1 (de) * 1985-09-24 1987-04-02 Hoechst Ag In 6- und 9-stellung substituierte 2-aminopurine, ihre verwendung, diese purine enthaltende arzneimittel und verfahren zur herstellung der purine
DE3534774A1 (de) * 1985-09-30 1987-04-02 Robugen Gmbh Nucleosid-analoge verbindungen mit antiviraler aktivitaet, verfahren zu deren herstellung sowie arzneimittel mit antiviraler wirkung
AP160A (en) * 1987-08-15 1991-11-18 The Wellcome Foundation Ltd Therapeutic acyclic nucleosides.

Also Published As

Publication number Publication date
DE3855333D1 (de) 1996-07-04
FI89713C (fi) 1993-11-10
DE3855333T2 (de) 1996-12-05
DK451388D0 (da) 1988-08-12
EP0308065B1 (en) 1995-01-04
NO883612L (no) 1989-02-16
AU2097888A (en) 1989-02-16
DK170803B1 (da) 1996-01-22
IL87434A0 (en) 1989-01-31
FI89713B (fi) 1993-07-30
LU88746I2 (fr) 1996-10-04
JPS6468373A (en) 1989-03-14
NO883612D0 (no) 1988-08-12
KR960002849B1 (ko) 1996-02-27
LV5264A3 (lv) 1993-10-10
MY103760A (en) 1993-09-30
ATE138660T1 (de) 1996-06-15
AP55A (en) 1989-09-26
NL960001I2 (nl) 1996-11-01
EP0596542B1 (en) 1996-05-29
JPH03115284A (ja) 1991-05-16
IE65551B1 (en) 1995-11-01
SG26346G (en) 1995-09-01
GR3020372T3 (en) 1996-09-30
IE882463L (en) 1989-02-15
IL87434A (en) 1993-06-10
SU1634138A3 (ru) 1991-03-07
NO167805C (no) 1991-12-11
CS276903B6 (en) 1992-09-16
CN1032538A (zh) 1989-04-26
ES2087639T3 (es) 1996-07-16
DK451388A (da) 1989-02-16
CN1033701C (zh) 1997-01-01
NL960001I1 (nl) 1996-03-01
AU612393C (en) 2006-08-17
DK82694A (da) 1994-07-08
NO167805B (no) 1991-09-02
EP0308065A3 (en) 1989-09-27
NZ225809A (en) 1991-07-26
NO1996015I1 (no) 1996-12-17
CY1833A (en) 1995-12-01
EP0308065A2 (en) 1989-03-22
FI883757A0 (fi) 1988-08-12
EP0596542A1 (en) 1994-05-11
AP8800099A0 (en) 1988-08-01
PL274215A1 (en) 1990-02-19
FI883757L (fi) 1989-02-16
KR960004940B1 (ko) 1996-04-18
PT88261A (pt) 1989-06-30
JPH0662623B2 (ja) 1994-08-17
JPH07113025B2 (ja) 1995-12-06
MX9203418A (es) 1992-07-01
HU201071B (en) 1990-09-28
DK170045B1 (da) 1995-05-08
PL158285B1 (en) 1992-08-31
SA95160244B1 (ar) 2006-10-02
CS8805594A2 (en) 1990-06-13
KR890003761A (ko) 1989-04-17
AU612393B2 (en) 1991-07-11
HUT47935A (en) 1989-04-28
AP160A (en) 1991-11-18
PT88261B (pt) 1995-03-01

Similar Documents

Publication Publication Date Title
MC1968A1 (fr) Procede de preparation de composes antiviraux et procede de preparation de formulations pharmaceutiques les contenant
US4957924A (en) Therapeutic valine esters of acyclovir and pharmaceutically acceptable salts thereof
US5840891A (en) 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
JP3090305B2 (ja) ２−（２−アミノ−１，６−ジヒドロ−６−オキソ−プリン−９−イル）メトキシ−１，３−プロパンジオール誘導体
MC1068A1 (fr) Derives de la purine et medicaments qui en contienprocede de preparation de derives de la purine nent
FI74468C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 2-aminopurinderivat.
EP0828742B1 (fr) Diazepino-indoles inhibiteurs de phosphodiesterases 4
MC1475A1 (fr) Procede de preparation de derives de la purine a action anti-virale
MC869A1 (fr) Furanosyl-aminopurines et médicament contenant ces substances
FR2723093A1 (fr) Esters d'acyle d'acides amines achiraux du glanciclovir
US5061708A (en) Therapeutic guanine esters
EP0772615B1 (fr) DERIVES D'ACIDE IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-2-CARBOXYLIQUE, LEUR PREPARATION ET LES MEDICAMENTS LES CONTENANT
EP1001943B1 (fr) Derives de polyhydroxyalkylpyrazines, leur preparation et medicaments les contenant
MC2071A1 (fr) Procedes pour la preparation de derives de nucleosides antiviraux et de formulations pharmaceutiques les contenant
CA1340084C (en) Esters of 9-(2-hydroxyethoxymethyl)guanine having antiviral properties
IE950194L (en) Therapeutic nucleosides
HK1012339B (en) 2-(2-amino-1, 6-dihydro-6-oxo-purin-9-yl)methoxy-1, 3-propanediol derivatives

Legal Events

Date Code Title Description
YP Annual fee paid